Chloroquine
Pharmaceutical forms
Tablet
Country lists
ATC N/A
Composition 200 mg
Observations for this pharmaceutical form can be found on the lists:
Venezuela (incomplete)
List of Generic Medications - Venezuela
  • No observations
Tablet
Country lists
ATC N/A
Composition 250mg
Observations for this pharmaceutical form can be found on the lists:
Ecuador
Essential Medicines List - Ecuador
  • No observations
Injection
Country lists
ATC N/A
Composition 50mg/ml
Observations for this pharmaceutical form can be found on the lists:
Ecuador
Essential Medicines List - Ecuador
  • No observations
Venezuela (incomplete)
List of Generic Medications - Venezuela
  • No observations
Injection
Country lists
ATC N/A
Composition 100 mg/ml (hydrochloride)
Observations for this pharmaceutical form can be found on the lists:
Venezuela (incomplete)
List of Generic Medications - Venezuela
  • No observations
Tablet
Country lists
ATC N/A
Composition 150 mg
Observations for this pharmaceutical form can be found on the lists:
Venezuela (incomplete)
List of Generic Medications - Venezuela
  • No observations
Cuba
2.4 Agentes modificadores de los trastornos reumatoideos
  • No observations
Cuba
6.1.1.2 Antipalúdicos
  • No observations
Tablet
Country lists
ATC N/A
Composition 100 mg (as phosphate or sulfate)
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
2.4. Disease modifying agents used in rheumatoid disorders (DMARDs)
  • Others observations:
    The Expert Committee has requested a review of the comparative effectiveness and safety, for possible deletion of this medicine at its next meeting.
WHO Model List of Essential Medicines
6.5.3.1. For curative treatment
  • Others observations:
    For use only for the treatment of P.vivax infection.
PAHO Strategic Fund Medicine List
2.7.2. Anti-malarial
  • No observations
Tablet
Country lists
ATC N/A
Composition 150 mg (as phosphate or sulfate)
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
2.4. Disease modifying agents used in rheumatoid disorders (DMARDs)
  • Others observations:
    The Expert Committee has requested a review of the comparative effectiveness and safety, for possible deletion of this medicine at its next meeting.
WHO Model List of Essential Medicines
6.5.3.2. For prophylaxis
  • Others observations:
    For use only in central American regions, for use for P.vivax.
WHO Model List of Essential Medicines
6.5.3.1. For curative treatment
  • Others observations:
    For use only for the treatment of P.vivax infection.
PAHO Strategic Fund Medicine List
2.7.2. Anti-malarial
  • No observations
Colombia
03. Antimalarials
  • No observations
Oral liquid
Country lists
ATC N/A
Composition 50 mg (as phosphate or sulfate)/5 ml
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.5.3.2. For prophylaxis
  • Others observations:
    For use only in central American regions, for use for P.vivax.
WHO Model List of Essential Medicines
6.5.3.1. For curative treatment
  • Others observations:
    For use only for the treatment of P.vivax infection.
PAHO Strategic Fund Medicine List
2.7.2. Anti-malarial
  • No observations
Tablet
Country lists
ATC N/A
Composition 150mg (phosphate)
Observations for this pharmaceutical form can be found on the lists:
Peru
6.5.3 Antimalarials
  • No observations
Oral liquid
Country lists
ATC N/A
Composition 25mg (as phosphate for sulfate)/5ml
Observations for this pharmaceutical form can be found on the lists:
Colombia
03. Antimalarials
  • No observations
Injection
Country lists
ATC N/A
Composition 60mg (as phosphate for sulfate)/2ml
Observations for this pharmaceutical form can be found on the lists:
Colombia
03. Antimalarials
  • No observations
Injection
Country lists
ATC N/A
Composition 420mg (as phosphate for sulfate)/5ml
Observations for this pharmaceutical form can be found on the lists:
Colombia
03. Antimalarials
  • No observations
Tablet
Country lists
ATC N/A
Composition 250mg (150mg base) as phosphate
Observations for this pharmaceutical form can be found on the lists:
Bolivia
LINAME 2011 - 2013
  • No observations